This adjustment in the GRSGWAS resulted in the removal of three SNPs from the GRSGWAS for IBD (in GCKR, IRF1, and PTPN2), five SNPs from the GRSGWAS for Crohn disease (in GCKR, IL6R, IRF1, PABPC4, and PTPN2), one SNP from the GRSGWAS for psoriatic arthritis (in IRF1), three SNPs for CAD (in APOC1, HNF1A, and IL6R), one SNP from the GRSGWAS for DBP (in PABPC4), two SNPs from the GRSGWAS for eGFRcr (in LEPR and GCKR), six SNPs from the GRSGWAS for serum albumin level (in APOC1, BCL7B, GCKR, PPP1R3B, PTPN2, and IRF1), and one SNP from the GRSGWAS for serum protein level (in GCKR). This evidence concerns the gene HNF1A and psoriatic arthritis.